Biotechnology, particularly medicinal-focused biotechnology, has garnered a lot of attention lately for making significant technological advances in improving human and animal health, notably with the advent of COVID-19 new medicines. Biotechnology, on the other hand, is driving advancements in bio-based materials, consumer goods, and chemicals. This subcategory, known as industrial biotechnology, involves producing bio-based polymers and synthetic fabrics, as well as conceptualising new uses for previously wasted biomass waste. Industrial biotechnologists are spearheading an amazing effort to develop environmentally friendly and cost-effective manufacturing solutions. The need for bio manufactured items are increasing, from vaccines to meat alternatives. However, the large-scale biomanufacturing infrastructure required to commercialise all of these products has been lacking. To meet the demand for fermentation-based animal protein by 2030, worldwide biomanufacturing capacity will have to rise 100 times.
Important Alert:
X
Title : Molecular therapeutics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Biotech scale-up: Bioengineering imperatives in biomanufacturing
Murray Moo Young, University of Waterloo, Canada
Title : A real BandAId™: Incorporating Artificial Intelligence (AI) into biomaterials and medicine
Thomas J Webster, Hebei University of Technology, China
Title : Modulation of alternative splicing as a novel therapeutic avenue in cancer
Sebastian Oltean, University of Exeter Medical School, United Kingdom
Title : Deep learning-based survival analysis of omics and clinicopathological data
Julia Sidorova, Centro de Investigación Biomédica en Red Enfermedades Hepáticas y Digestivas (CIBEREHD), Spain
Title : Antimicrobial electrospun fibrous scaffolds and their potential use as wound dressings
Luis Jesus Villarreal Gomez, Universidad Autonoma de Baja California, Mexico